Literature DB >> 28747334

PEDF expression affects retinal endothelial cell proangiogenic properties through alterations in cell adhesive mechanisms.

Juliana Falero-Perez1,2, SunYoung Park1, Christine M Sorenson2,3, Nader Sheibani4,2,5,6.   

Abstract

Pigment epithelium-derived factor (PEDF) is an endogenous inhibitor of angiogenesis. Although various ocular cell types including retinal endothelial cells (EC) produce PEDF, we know very little about cell autonomous effects of PEDF in these cell types. Here we determined how PEDF expression affects retinal EC proangiogenic properties. Retinal EC were prepared from wild-type (PEDF+/+) and PEDF-deficient (PEDF-/-) mice. The identity of EC was confirmed by staining for specific markers including vascular endothelial cadherin, CD31, and B4-lectin. Retinal EC also expressed VEGF receptor 1 and endoglin, as well as ICAM-1, ICAM-2, and VCAM-1. PEDF-/- retinal EC were more proliferative, less apoptotic when challenged with H2O2, less migratory, and less adherent compared with PEDF+/+ EC. These changes could be associated, at least in part, with increased levels of tenascin-C, fibronectin, thrombospondin-1 and collagen IV, and lower amounts of osteopontin. PEDF-/- EC also exhibited alterations in expression of a number of integrins including α2, αv, β1, β8, and αvβ3, and cell-cell adhesion molecules including CD31, zonula occluden-1, and occludin. These observations correlated with attenuation of capillary morphogenesis and increased levels of oxidative stress in PEDF-/- EC. PEDF-/- EC also produced lower levels of VEGF compared with PEDF+/+ cells. Thus, PEDF deficiency has a significant impact on retinal EC adhesion and migration, perhaps through altered production of extracellular matrix and junctional proteins in response to increased oxidative stress affecting their proangiogenic activity.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  adherens junctions; extracellular matrix; inflammation; integrins; tight junctions

Mesh:

Substances:

Year:  2017        PMID: 28747334      PMCID: PMC5668572          DOI: 10.1152/ajpcell.00004.2017

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  79 in total

1.  Pigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1/2 and induction of Bcl-2.

Authors:  A Sanchez; D Tripathy; X Yin; J Luo; J Martinez; P Grammas
Journal:  Neurosci Res       Date:  2011-09-17       Impact factor: 3.304

Review 2.  Flow-mediated endothelial mechanotransduction.

Authors:  P F Davies
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

3.  [The effect of rAAV2-PEDF on proliferation of human retinal capillary endothelium cells].

Authors:  Tao Li; Hong-jie Ma; Xiao-ling Liang; Xiao-yan Ding; Yan Luo; Shao-fen Lin; Shi-bo Tang
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2011-03

4.  Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.

Authors:  Yanling Liu; Lan Franco Leo; Corban McGregor; Anzor Grivitishvili; Colin J Barnstable; Joyce Tombran-Tink
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

5.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family.

Authors:  F R Steele; G J Chader; L V Johnson; J Tombran-Tink
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

6.  Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes.

Authors:  Shoujian Wang; Justin L Gottlieb; Christine M Sorenson; Nader Sheibani
Journal:  Arch Ophthalmol       Date:  2009-04

7.  Pigment epithelium-derived factor is retinal ganglion cell neuroprotective and axogenic after optic nerve crush injury.

Authors:  Vasanthy Vigneswara; Martin Berry; Ann Logan; Zubair Ahmed
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-12       Impact factor: 4.799

8.  Pigment epithelium-derived factor protects cone photoreceptor-derived 661W cells from light damage through Akt activation.

Authors:  Matthew Rapp; Grace Woo; Muayyad R Al-Ubaidi; S Patricia Becerra; Preeti Subramanian
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  Pigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cells.

Authors:  Jan Darius Unterlauft; Wolfram Eichler; Konstantin Kuhne; Xiu Mei Yang; Yousef Yafai; Peter Wiedemann; Andreas Reichenbach; Thomas Claudepierre
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

10.  Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.

Authors:  Tung-Han Tsai; Shou-Chuan Shih; Tsung-Chuan Ho; Hsin-I Ma; Ming-Ying Liu; Show-Li Chen; Yeou-Ping Tsao
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

View more
  5 in total

1.  PEDF expression affects the oxidative and inflammatory state of choroidal endothelial cells.

Authors:  Mitra Farnoodian; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-10       Impact factor: 4.249

Review 2.  Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.

Authors:  Wenjing Xu; Chunping Ye; Xin Qing; Shengli Liu; Xinyi Lv; Wenjun Wang; Xiaochen Dong; Yewei Zhang
Journal:  Mater Today Bio       Date:  2022-07-12

Review 3.  Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.

Authors:  Fangmin Chen; Yifan Fang; Xiang Chen; Rui Deng; Yongjie Zhang; Jingwei Shao
Journal:  Asian J Pharm Sci       Date:  2020-08-21       Impact factor: 6.598

4.  Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization.

Authors:  Maria Hernandez; Sergio Recalde; Laura Garcia-Garcia; Jaione Bezunartea; Csaba Miskey; Sandra Johnen; Sabine Diarra; Attila Sebe; Juan Roberto Rodriguez-Madoz; Severine Pouillot; Corinne Marie; Zsuzsanna Izsvák; Daniel Scherman; Martina Kropp; Felipe Prosper; Gabriele Thumann; Zoltán Ivics; Alfredo Garcia-Layana; Patricia Fernandez-Robredo
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-09       Impact factor: 6.698

5.  Caffeine Inhibits Choroidal Neovascularization Through Mitigation of Inflammatory and Angiogenesis Activities.

Authors:  Christine M Sorenson; Yong-Seok Song; Ismail S Zaitoun; Shoujian Wang; Barbara A Hanna; Soesiawati R Darjatmoko; Zafer Gurel; Debra L Fisk; Colleen M McDowell; Ryan M McAdams; Nader Sheibani
Journal:  Front Cell Dev Biol       Date:  2021-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.